AptarGroup, Inc., often referred to as Aptar, is a prominent player in the design and manufacturing of drug and consumer product dosing, dispensing, and protection technologies. The company operates across various end markets, including pharmaceutical, beauty, food, beverage, personal care, and home care. With a presence in 20 countries and approximately 13,800 dedicated employees, Aptar caters to a diverse range of customers, many of whom are leading brands globally. Aptar's primary offerings include dispensing pumps, closures, aerosol valves,...
| S.No. | Ticker | Company | Market Cap | P/E | P/S | Total Debt (Qtr) |
|---|---|---|---|---|---|---|
| 1 | ISRG | Intuitive Surgical Inc | 209.14 Bn | 76.14 | 21.76 | 0.00 Bn |
| 2 | BDX | Becton Dickinson & Co | 58.36 Bn | 34.78 | 2.67 | 19.18 Bn |
| 3 | ALC | Alcon Inc | 39.57 Bn | 37.80 | 3.89 | 5.24 Bn |
| 4 | RMD | Resmed Inc | 37.01 Bn | 25.74 | 7.04 | 0.85 Bn |
| 5 | WST | West Pharmaceutical Services Inc | 19.95 Bn | 40.58 | 6.61 | 0.30 Bn |
| 6 | HOLX | Hologic Inc | 16.94 Bn | 29.95 | 4.13 | 2.52 Bn |
| 7 | COO | Cooper Companies, Inc. | 16.64 Bn | 44.39 | 4.07 | 2.51 Bn |
| 8 | SOLV | Solventum Corp | 15.00 Bn | 9.84 | 1.79 | 5.14 Bn |
| Current Valuation | Value | Ind Avg | Percentile |
|---|---|---|---|
| EV to Assets EV to Assets | 1.69 | 3.14 | |
| EV to Cash from Ops. EV/CFO | 15.27 | 37.60 | |
| EV to Debt EV to Debt | 12.25 | 23.10 | |
| EV to EBIT EV/EBIT | 15.30 | 50.25 | |
| EV to EBITDA EV/EBITDA | 10.87 | 19.58 | |
| EV to Free Cash Flow [EV/FCF] EV/FCF | 27.15 | -19.40 | |
| EV to Market Cap EV to Market Cap | 1.05 | -1.68 | |
| EV to Revenue EV/Rev | 2.35 | 171.31 | |
| Price to Book Value [P/B] P/B | 2.95 | 6.03 | |
| Price to Earnings [P/E] P/E | 19.50 | 204.20 |
| Dividend Metrics | Value | Ind Avg | Percentile |
|---|---|---|---|
| Dividend Coverage Ratio Div Coverage (Qtr) | 3.52 | -1.11 | |
| Dividend Payout Ratio % Div Payout % (Qtr) | 28.30 | 1.52 | |
| Dividend per Basic Share Div per Share (Qtr) | 1.35 | 0.25 | |
| FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) | 27.94 | 8.75 | |
| Interest Coverage Int. cover (Qtr) | 11.96 | -119.10 |
| Growth Metrics | Value | Ind Avg | Percentile |
|---|---|---|---|
| Capex Growth (1y) % Capex 1y % (Qtr) | 15.16 | -55.01 | |
| Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) | -21.03 | 200.65 | |
| Dividend Growth (1y) % Div 1y % (Qtr) | -21.51 | -1.49 | |
| EBIAT Growth (1y) % EBIAT 1y % (Qtr) | 23.95 | -56.39 | |
| EBITDA Growth (1y) % EBITDA 1y % (Qtr) | 9.95 | -106.80 | |
| EBIT Growth (1y) % EBIT 1y % (Qtr) | 17.91 | -36.51 | |
| EBT Growth (1y) % EBT 1y % (Qtr) | 18.75 | -47.44 | |
| EPS Growth (1y) % EPS 1y % (Qtr) | 25.00 | -15.70 | |
| FCF Growth (1y) % FCF 1y % (Qtr) | -19.34 | 59.41 | |
| Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) | 4.30 | 68.22 |
| Liquidity Ratios | Value | Ind Avg | Percentile |
|---|---|---|---|
| Asset Utilization Ratio Asset Util Ratio (Qtr) | 0.72 | 0.54 | |
| Cash Payout Ratio Cash Payout (Qtr) | 0.15 | 0.03 | |
| Cash Ratio Cash Ratio (Qtr) | 0.17 | 2.49 | |
| Current Ratio Curr Ratio (Qtr) | 1.19 | 7.77 | |
| Debt to Equity Ratio Debt/Equity (Qtr) | 0.25 | 0.55 | |
| Interest Cover Ratio Int Coverage (Qtr) | 11.96 | -119.10 | |
| Times Interest Earned Times Interest Earned (Qtr) | 11.96 | -119.10 |
| Profitability | Value | Ind Avg | Percentile |
|---|---|---|---|
| EBITDA Margin % EBITDA Margin % (Qtr) | 23.00 | -2,368.64 | |
| EBIT Margin % EBIT Margin % (Qtr) | 15.38 | -2,472.65 | |
| EBT Margin % EBT Margin % (Qtr) | 14.09 | -2,442.59 | |
| Gross Margin % Gross Margin % (Qtr) | 38.10 | 30.07 | |
| Net Profit Margin % Net Margin % (Qtr) | 11.50 | -2,438.52 |